NUVB
Nuvation Bio Inc.
NYSE · Healthcare · Biotechnology · US
$6.81
+0.59%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 11.30x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 9.42x
- Price / sales
- 14.07x
- Price / cash flow
- -28.94x
Enterprise value
- Enterprise value
- $2.0B
- EV / sales
- 11.67x
- EV / EBITDA
- -15.60x
- EV / EBIT
- -14.40x
- Market cap
- $2.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026